Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion
CNBC - 2024-04-10T20:32:07.000Z

With the acquisition, Vertex will add Alpine's portfolio of protein-based immunotherapies to treat autoimmune and inflammatory diseases.

In related news

Samsung to receive $6.4 billion from the CHIPS and Science Act
Samsung is going to get $6.4 billion from the US CHIPS and Science Act. As part of the arrangement, the company has promised to invest $40 billion in and around Austin, Texas, in the coming years.
- Related Articles
- In News
- From Neowin
- 2024-04-16T01:30:01.000Z
Hong Kong housing chief defends HK$4.4 billion operating costs of temporary housing scheme
Hong Kong’s housing minister has defended an estimated HK$4.39 billion price tag for managing 30,000 temporary flats which are planned for the city, saying this would cover maintenance, cleaning, and other amenities. The units will be part of the Light Public Housing (LPH) scheme, which aims to boost the city’s short-term housing supply by providing […]
- Related Articles
- In News
- From Hong Kong Free Press HKFP
- 2024-04-18T10:55:57.000Z
What $26 Billion Buys
Today on TAP: Netanyahu ignores Biden’s warnings and plans an imminent operation in Rafah.
- Related Articles
- In News
- From The American Prospect
- 2024-04-23T15:00:00.000Z